View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 07/01/2025

Acqua e Sapone: high cash burn in Q1 and higher leverage|Flos B&B Italia Group dissolves its joint venture with Fendi|BBVA goes ahead with Sabadell offer|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 01/07/2025

Acqua e Sapone : consommation de cash importante au T1 et hausse du levier|Flos B&B Italia met fin à sa JV avec Fendi|BBVA décide de poursuivre son offre sur Sabadell|

Delphine Brault ... (+2)
  • Delphine Brault
  • Steven Boumans
Delphine Brault ... (+2)
  • Delphine Brault
  • Steven Boumans
Chris Hoare
  • Chris Hoare

Global EM Telcos & Towers Another decent month: NSR GEM Top-10 July ‘...

Our picks largely had a slightly slower month in June, with VEON seeing sharp profit taking, but a recovery in some of the weaker stocks such as LILAK offset to continue to see overall valuations rise. We continue to see the EM Telco cycle in an upswing. This note also includes key news & other thoughts, to try to help investors generate alpha within the EM Telco space. In our view, our picks remain heavily undervalued, so we make no changes to the list.

Carole Braudeau
  • Carole Braudeau

Credit Morning 06/30/2025

Worldline: Belgian authorities open investigation into local subsidiary for money laundering|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 30/06/2025

Worldline : la justice belge ouvre une enquête sur la filiale locale pour blanchiment d’argent|

Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt
Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch